A Phase 1, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of SHR-1316 in Subjects with Advanced Solid Tumors

Project: Research

StatusActive
Effective start/end date28/02/1927/02/24